Skip to main content

Advertisement

Log in

Topical Controlled Warm Oxygen Therapy Delivered Through a Novel Device (KADAM™) to Treat Diabetic Foot Ulcers: A Randomized Controlled, Open, Pilot Trial

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Adjunctive topical oxygen therapy offers promise in accelerating diabetic foot ulcer healing. We hypothesize that topical warm oxygen delivered at a controlled temperature (42 °C) through a proprietary device (KADAM™) will improve ulcer healing and be well-tolerated among patients with type 2 diabetes mellitus and with foot ulcers of Wagner-Meggitt grades 2 and 3. This trial employed a randomized controlled, open label design, with the outcome assessor blinded to allocation. We randomized 20 patients in a 1:1 allocation ratio, to intervention and control (standard of care) arms. The intervention arm received in-hospital topical warm oxygen at 42 °C for 90 min/session. This was repeated on alternate days for 6 weeks (18 sessions). Patients in the control group got standard care, and all received standard wound care. The primary outcome was a change in the ulcer area from baseline visit to follow-up at 6 weeks, day 5. There was a significant reduction in the area of the ulcer in the intervention group between baseline and week 6, day 5 [log area intervention group baseline vs week 6 day 5, 2.72 (0.57) vs 1.54 (0.95), change =  − 1.18 (− 0.58, − 1.78), p = 0.019]. Between-group ulcer area at week 6, day 5, was also significantly different [intervention vs control (log area), 1.54 (0.95) vs 2.94 (1.05), p = 0.005], with the difference favoring the intervention group. There were no adverse reactions in the intervention arm. Adjunctive topical warm oxygen delivered at 42 °C and normal pressure can potentially improve diabetic foot ulcer healing and is well-tolerated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

The data are currently in the possession of the investigators of the study. We can consider making the de-identified data available upon request. Please contact the corresponding author for requests pertaining to data access.

References

  1. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW et al (2018) IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281

    Article  CAS  Google Scholar 

  2. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018 Dec 1;6(12):e1352–62

  3. Jain AKC, Viswanath S (2016) Studying major amputations in a developing country using Amit Jain’s typing and scoring system for diabetic foot complications - time for standardization of diabetic foot practice. Int Surg J 2(1):26–30

    Article  Google Scholar 

  4. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y (2017) Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis †. Ann Med 49(2):106–116

    Article  Google Scholar 

  5. Maiya AG, Gundmi S, Matpady P, Jadhav R, Lingadakai R, Hande M et al (2018) Prevalence of foot complications in people with type 2 Diabetes Mellitus: A community-based survey in Rural Udupi. Int J Low Extrem Wounds 17(3):169–175

    Article  Google Scholar 

  6. Management of diabetic foot wounds - UpToDate [Internet]. [cited 2020 May 5]. Available from: https://www.uptodate.com/contents/image?imageKey=SURG%2F103017&topicKey=SURG%2F8175&search=diabetic%20foot%20ulcer&rank=1~42&source=see_link

  7. Cañedo-Dorantes L, Cañedo-Ayala M. Skin acute wound healing: a comprehensive review. Int J Inflamm [Internet]. 2019 Jun 2;2019. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582859/. Accessed 23 Aug 2021  

  8. Rabkin JM, Hunt TK (1987) Local heat increases blood flow and oxygen tension in wounds. Arch Surg Chic Ill 1960 122(2):221–5

    CAS  Google Scholar 

  9. Yazdanpanah L, Nasiri M, Adarvishi S (2015) Literature review on the management of diabetic foot ulcer. World J Diabetes 6(1):37–53

    Article  Google Scholar 

  10. Blackman E, Moore C, Hyatt J, Railton R, Frye C (2010) Topical wound oxygen therapy in the treatment of severe diabetic foot ulcers: a prospective controlled study. Ostomy Wound Manage 56(6):24–31

    PubMed  Google Scholar 

  11. Gordillo GM, Sen CK (2009) Evidence-based recommendations for the use of topical oxygen therapy in the treatment of lower extremity wounds. Int J Low Extrem Wounds 8(2):105–111

    Article  Google Scholar 

  12. Health C for D and R. Topical Oxygen Chamber for Extremities - Class II Special Controls Guidance for Industry and FDA Staff. FDA [Internet]. 2020 Feb 27 [cited 2020 May 5]; Available from: https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/topical-oxygen-chamber-extremities-class-ii-special-controls-guidance-industry-and-fda-staff

  13. Hayes PD, Alzuhir N, Curran G, Loftus IM (2017) Topical oxygen therapy promotes the healing of chronic diabetic foot ulcers: a pilot study. J Wound Care 26(11):652–60

    Article  CAS  Google Scholar 

  14. Nataraj M, Maiya AG, Karkada G, Hande M, Rodrigues GS, Shenoy R et al (2019) Application of topical oxygen therapy in healing dynamics of diabetic foot ulcers - a systematic review. Rev Diabet Stud RDS 15:74–82

    Article  Google Scholar 

  15. Joshi VS, Joshi SS, Maruthy (2017) Systemic and local effects of warm oxygen exposure to the lower extremities in healthy volunteers. J Clin Diagn Res JCDR 11(4):CC01–CC03

    PubMed  Google Scholar 

  16. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A (2003) Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 26(6):1879–1882

    Article  Google Scholar 

  17. Driver VR, Yao M, Kantarci A, Gu G, Park N, Hasturk H (2013) A prospective, randomized clinical study evaluating the effect of transdermal continuous oxygen therapy on biological processes and foot ulcer healing in persons with diabetes mellitus. Ostomy Wound Manage 59(11):19–26

    PubMed  Google Scholar 

  18. PRIME PubMed | A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Stud [Internet]. [cited 2020 May 5]. Available from: https://www.unboundmedicine.com/medline/citation/31619393/A_Multinational,_Multicenter,_Randomized,_Double-Blinded,_Placebo-Controlled_Trial_to_Evaluate_the_Efficacy_of_Cyclical_Topical_Wound_Oxygen_Therapy_(TWO2)_in_the_Treatment_of_Chronic_Diabetic_Foot_Ulcers:_The_TWO2_Study

  19. Howard MA, Asmis R, Evans KK, Mustoe TA (2013) Oxygen and wound care: a review of current therapeutic modalities and future direction. Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc 21(4):503–511

    Google Scholar 

  20. de Smet GHJ, Kroese LF, Menon AG, Jeekel J, van Pelt AWJ, Kleinrensink G-J et al (2017) Oxygen therapies and their effects on wound healing. Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc 25(4):591–608

    Google Scholar 

Download references

Funding

Department of Biotechnology (DBT)/BIRAC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Y. Kamath.

Ethics declarations

Conflict of Interest

Dr. Anirudh V, Dr. Deepak Kamath (Kamath DY), Dr. Bhuvana KB, and Dr. Denis Xavier (Xavier D) were contracted by Yostra Labs Pvt Ltd, Bengaluru India, to develop the protocol and conduct the trial. They have not availed of any personal fees for this purpose, with the funds being utilized solely for study conduct and coordination. Dr. Maruthy K and Dr. Sanjay Sharma (Sharma S) are co-founders of Yostra Labs Pvt Ltd and are the principal grant recipients from DBT-BIRAC. Dr. Maruthy K has been involved with protocol development and have advised on matters related to the intervention. Yostra Labs Pvt Ltd does not own the data and has not been involved in the analysis, but Dr Maruthy K and Dr Sanjay Sharma have reviewed the manuscript. Dr. Prem Pais (Pais P) has no relevant conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anirudh, V., Kamath, D.Y., Ghosh, S. et al. Topical Controlled Warm Oxygen Therapy Delivered Through a Novel Device (KADAM™) to Treat Diabetic Foot Ulcers: A Randomized Controlled, Open, Pilot Trial. Indian J Surg 83 (Suppl 4), 907–914 (2021). https://doi.org/10.1007/s12262-021-03057-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-021-03057-w

Keywords

Navigation